docetaxel anhydrous has been researched along with paraquat in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (paraquat) | Trials (paraquat) | Recent Studies (post-2010) (paraquat) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 5,741 | 25 | 1,991 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellezza, I; Gatticchi, L; Grottelli, S; Mierla, AL; Minelli, A | 1 |
1 other study(ies) available for docetaxel anhydrous and paraquat
| Article | Year |
|---|---|
α-Tocopheryl succinate pre-treatment attenuates quinone toxicity in prostate cancer PC3 cells.
Topics: Active Transport, Cell Nucleus; alpha-Tocopherol; Antioxidants; Apoptosis; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA-Binding Proteins; Docetaxel; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Glutathione; Heme Oxygenase-1; Humans; Hydrogen Peroxide; Hydroquinones; Male; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Paraquat; Prostatic Neoplasms; Protoporphyrins; RNA Interference; RNA, Small Interfering; Taxoids | 2014 |